PixarBio Corporation

PixarBio Corporation is a pharmaceutical/medical device company headquartered in Fort Lee, New Jersey. The company is a small business with 3 employees and generates revenue exceeding $10,000. PixarBio Corporation specializes in developing NeuroRelease, a novel neurological drug delivery system designed to treat post-operative pain. The company's focus is on creating targeted delivery systems for drugs, devices, or biologics to address a range of neurological conditions, including pain, epilepsy, Parkinson's disease, and spinal cord injury. The company's lead product platform, NeuroRelease™, has demonstrated efficacy in pre-clinical models, achieving sustained therapeutic release of non-opiate drugs for post-operative, acute, and chronic pain. You can learn more about PixarBio Corporation and its innovative drug delivery solutions by visiting their website at pixarbio.com.